Skip to main content
DNA Labs India

SLC25A22 Gene Early infantile epileptic encephalopathy type 3 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

SLC25A22 Gene Early infantile epileptic encephalopathy type 3 NGS Genetic Test

Short Name: SLC25A22 Gene EIEE Type 3 Test

Also known as: EIEE3, SLC25A22-related epilepsy, Early infantile epileptic encephalopathy type 3

SLC25A22 Gene Early infantile epileptic encephalopathy type 3 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.

NGS Genetic TestPediatric🏠 Home Collection

✍️ Written By

🩺 Medically Reviewed By

Dr SULOCHANA HEMCHANDRA HOLLA

Dr SULOCHANA HEMCHANDRA HOLLA

Consultant Medical Geneticist · Reg: 8532

Last reviewed: September 7, 2026

Overview

The purpose of the SLC25A22 Gene EIEE Type 3 NGS Genetic Test is to identify mutations in the SLC25A22 gene that cause early infantile epileptic encephalopathy type 3. This helps in confirming the diagnosis, differentiating from other epileptic encephalopathies, and informing treatment and management strategies.

Test Code
1606
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation is needed. Inform the lab about any medications or health conditions.

Method: Venipuncture

Step 2

Laboratory Analysis

A small blood sample will be drawn from a vein in the arm by a trained professional.

Step 3

Report Delivery

Apply pressure to the puncture site to stop bleeding. Resume normal activities.

Timeline: 3 to 4 weeks

Patient Instructions

1
Before the Test:No specific preparation is needed. Inform the lab about any medications or health conditions.
2
During the Test:A small blood sample will be drawn from a vein in the arm.
3
After the Test:Apply pressure to the puncture site to stop bleeding. Resume normal activities.

About This Test

Who Should Get This Test

The purpose of the SLC25A22 Gene EIEE Type 3 NGS Genetic Test is to identify mutations in the SLC25A22 gene that cause early infantile epileptic encephalopathy type 3. This helps in confirming the diagnosis, differentiating from other epileptic encephalopathies, and informing treatment and management strategies.

How to Prepare

  • No fasting required
  • Bring a valid ID and doctor's referral if available
  • Wear loose clothing for blood draw

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic testing for SLC25A22 gene mutations is essential for diagnosing EIEE Type 3, allowing for early intervention and genetic counseling for affected families."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Collection MethodVenipuncture
Sample Rejection Criteria:
  • Insufficient sample volume
  • Sample labeled incorrectly
  • Clotted or hemolyzed sample

Understanding Your Results

Results from the SLC25A22 Gene Test are interpreted by genetic specialists. A positive result indicates the presence of a pathogenic mutation associated with EIEE Type 3.
Negative: No pathogenic variants detected in the SLC25A22 gene.
Positive: One or more pathogenic variants identified, confirming diagnosis of EIEE Type 3.
Variant of uncertain significance: Further testing or family studies may be required.
⚠️ When to Consult a Doctor:

Consult a genetic specialist or neurologist if the test is positive, or if the infant shows symptoms of seizures or developmental delays.

Limitations

  • ⚠May not detect all types of mutations
  • ⚠Results require interpretation by a genetic counselor
  • ⚠Test does not assess for other genetic causes of epilepsy

Risks & Considerations

  • ●Mild pain or bruising at the needle site
  • ●Rare risk of infection or fainting

Interfering Factors

  • ●Sample contamination
  • ●Degraded DNA
  • ●Hemolysis in blood sample

Frequently Asked Questions

What is the SLC25A22 Gene EIEE Type 3 NGS Genetic Test?
This test uses next-generation sequencing to detect mutations in the SLC25A22 gene, which causes early infantile epileptic encephalopathy type 3 (EIEE Type 3).
Why is this test recommended for infants with seizures?
It is recommended to diagnose EIEE Type 3, a genetic cause of severe early-onset seizures, enabling targeted management and genetic counseling.
What sample is required for this test?
The test can be performed on a blood sample, extracted DNA, or one drop of blood on an FTA card.
How is the test performed?
Next-generation sequencing (NGS) technology is used to analyze the SLC25A22 gene for pathogenic mutations.
What is the cost of the test in India?
The cost is INR 20,000, which may vary slightly by location, with free home sample collection available across India.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings in numerous cities across India.
How long does it take to get the test results?
Results are typically available within 3 to 4 weeks after sample receipt.
What do the test results indicate?
A positive result confirms a diagnosis of EIEE Type 3 due to SLC25A22 mutations, while a negative result indicates no pathogenic variants detected.
Is genetic counseling included with the test?
Yes, DNA Labs India provides genetic counseling to help interpret results and guide families on next steps.
Can this test be used for prenatal diagnosis?
This test is primarily for postnatal diagnosis; for prenatal cases, consult a genetic specialist for appropriate testing options.
Is the test covered by insurance schemes like PMJAY or CGHS?
Coverage under government schemes like PMJAY or CGHS is not guaranteed; check with the respective authority or insurer for details.
How can I book this test with DNA Labs India?
You can book the test online via the DNA Labs India website or contact them via phone or WhatsApp for assistance.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

Angelman Syndrome Test

₹10,000

Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test

₹14,000

Episodic Ataxia Type 1 Hotspot Test

₹11,500

Episodic Ataxia Comprehensive Profile Hotspot Test

₹16,000

Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test

₹7,500

Analyzer 18 SMA 18 Test Panel

₹1,755
For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.